{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:10Z","timestamp":1791357490554,"version":"4.3.1"},"reference-count":46,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Otsuka Pharmaceutical Development & Commercialization, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2024,8,2]]},"DOI":"10.1080\/03007995.2024.2373883","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T15:03:48Z","timestamp":1720019028000},"page":"1397-1406","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of centanafadine in adults with ADHD: a matching adjusted indirect comparison versus methylphenidate hydrochloride extended release (Concerta)"],"prefix":"10.1080","volume":"40","author":[{"given":"Jeff","family":"Schein","sequence":"first","affiliation":[{"name":"Otsuka Pharmaceutical Development & Commercialization, Inc","place":["Princeton, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cloutier","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Montr\u00e9al, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolaine","family":"Gauthier-Loiselle","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["Montr\u00e9al, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryaline","family":"Catillon","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Xu","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Qu","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Childress","sequence":"additional","affiliation":[{"name":"Psychiatry and Behavioral Medicine, Center for Psychiatry and Behavioral Medicine","place":["Las Vegas, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"National Institute of Health National Institute of Mental Health. Attention-deficit\/hyperactivity disorder (ADHD); 2019 [2019 Jul 11]. Available from: https:\/\/www.nimh.nih.gov\/health\/statistics\/attention-deficit-hyperactivity-disorder-adhd.shtml"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1017\/S003329170500471X"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.145185"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.6.593"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.4.716"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.5.619"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30032-3"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsm002"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-10-67"},{"key":"e_1_3_5_11_1","first-page":"84","article-title":"A systematic review of global publication trends regarding long-term outcomes of ADHD","volume":"2","author":"Hodgkins P","year":"2011","unstructured":"Hodgkins P, Arnold LE, Shaw M, et\u00a0al. A systematic review of global publication trends regarding long-term outcomes of ADHD. Front Psychiatry. 2011;2:84.","journal-title":"Front Psychiatry"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9981-9"},{"issue":"1","key":"e_1_3_5_13_1","first-page":"27","article-title":"The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earnings","volume":"16","author":"Kotsopoulos N","year":"2013","unstructured":"Kotsopoulos N, Connolly MP, Sobanski E, et\u00a0al. The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earnings. J Ment Health Policy Econ. 2013;16(1):27\u201333.","journal-title":"J Ment Health Policy Econ"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2013.10.003"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apnu.2014.10.001"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2016.05.002"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2122228"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.20"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/ndt.s1747"},{"key":"e_1_3_5_20_1","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2017 National Survey on Drug Use and Health: detailed tables 2017. Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/NSDUHDetailedTabs2017\/NSDUHDetailedTabs2017.htm#tab1-25D."},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2215-0366(18)30269-4"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.1083394"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33004-1"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2017.1354648"},{"key":"e_1_3_5_25_1","unstructured":"Otsuka announces positive top-line results from two phase 3 studies of centanafadine for the treatment of attention-deficit hyperactivity disorder (ADHD) in adult patients; 2020 [Internet]. Available from: https:\/\/www.otsuka-us.com\/discover\/otsuka-announces-positive-top-line-results-from-two-phase-3-studies-of-centanafadine."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001575"},{"key":"e_1_3_5_27_1","unstructured":"Takeda Pharmaceuticals America Inc. Vyvanse (lisdexamfetamine dimesylate): Prescribing information; 2022."},{"key":"e_1_3_5_28_1","unstructured":"Lilly USA LLC. Strattera (atomoxetine): Prescribing information; 2020."},{"key":"e_1_3_5_29_1","unstructured":"Children and Adults with Attention-Deficit\/Hyperactivity Disorder (CHADD). Medication management Lanham MD2023; 2023 [cited Mar 23]. Available from: https:\/\/chadd.org\/for-parents\/managing-medication\/."},{"key":"e_1_3_5_30_1","unstructured":"Supernus Pharmaceuticals Inc. Qelbree (viloxazine extended-release capsules): Prescribing information; 2022."},{"key":"e_1_3_5_31_1","first-page":"528","volume-title":"Assessment of centanafadine in adults with attention-deficit\/hyperactivity disorder: a matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release","author":"Schein J","year":"2024","unstructured":"Schein J, Cloutier M, Gauthier-Loiselle M, et\u00a0al. Assessment of centanafadine in adults with attention-deficit\/hyperactivity disorder: a matching-adjusted indirect comparison vs lisdexamfetamine dimesylate, atomoxetine hydrochloride, and viloxazine extended-release. J Manag Care Spec Pharm. 2024;30(6):528\u2013540."},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S65721"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1968814"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-04016-9"},{"key":"e_1_3_5_35_1","unstructured":"Janssen Pharmaceuticals Inc. Concerta (methylphenidate HCl extended-release tablets): Prescribing information; 2023."},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/1087054709347435"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m10348"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01692-9"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102543"},{"issue":"1","key":"e_1_3_5_40_1","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li F","year":"2019","unstructured":"Li F, Thomas LE, Li F. Addressing extreme propensity scores via the overlap weights. Am J Epidemiol. 2019; 188(1):250\u2013257.","journal-title":"Am J Epidemiol"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/asn055"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu469"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8805"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.2019.1660173"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018174"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1207-9851"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.13r01600"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2024.2373883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:39:42Z","timestamp":1741628382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2024.2373883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,2]]}},"alternative-id":["10.1080\/03007995.2024.2373883"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2024.2373883","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}